Professional Services for the R&D Stakeholders Worldwide

Online, November 22, 2010 (Newswire.com) - UK based MNC,Helix Research Center Ltd has announced 'Professional Services' for the R&D Stakeholders like Pharmaceutical,Biotechnology,Medical Device,Cosmetic companies;Global Voluntary Organisations,Government Agencies such as National Institutes of Health (NIH),World Health Organisation(WHO),GAVI Alliance (Global Alliance of Vaccination and Immunisation) which was formed by World Health Organisation,The World Bank,The Bill and Melinda Gates Foundation and UNICEF,Non Profit Organisations,Public-Private Partnerships etc in North America,South America,Europe,Africa,Asia and Oceania/Australia.

It is a well known truth that the Global Research and Development(R&D) Stakeholders spend Billions of Dollars for New Drug Discovery,in order to add Effective Medicines/Treatments to the 'Armoury' of Healthcare Providers;the Ministries of Health of every Country inroder to Combat the Ruthless,Fatal Diseases that cause Milliions of Deaths/Disability amongst the World Community every year.Helix has taken an Initiative to provide Professional Services to the Sponsors of 'Industry Initiated ' and 'Investigator Initiated' Clinical Trials,inorder to add Value to the Efforts of the Sponsors,Researchers and Regulatory Authorities to, Ensure Protection of Human/Animal Rights,Safety and Well being of Trial Subjects and Confidentiality of Medical Information;avoid Errors,Report and Treat Adverse Events,Produce Quality Data,expedite the tasks within Timelines etc.

Some of the Professional Services announced by Helix include Pre Clinical,BA/BE,Phase 0 through IV,Regulatory,Medical Writing,Auditing,Quality Assurance,Clinical Data Management,Imaging,Translation,Biostatistics,Pharmacovigilance,SiteManagement/Trial Management,GCP Taining for Principal Investigators,Research Nurses and other Support Staff.

Helix is always keen to explore working relation with Global Clinical Research and Healthcare Fraternity and other like minded groups to Promote Preventive Healthcare and Continuing Research and Medical Education Programs.